Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1e0b5c59ca951e064c5609e7f752db1 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-00032 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-00033 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-10132 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6927 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 |
filingDate |
2015-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d7de9c0c06d9424bb8d42600c72422e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e6260b715ead8d95a052f7075d5bc1d |
publicationDate |
2015-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2015118150-A2 |
titleOfInvention |
Treatment of topical and systemic bacterial infections |
abstract |
Bacteriophage covalently attached to a carrier particle with an average diameter of from 0.1 microns to 15 microns, are used in topical treatment of bacterial infection. Bacteriophage covalently attached to a carrier particle of average diameter 7 microns or less are used in systemic treatment of bacterial infection. A plurality of bacteriophages lytic against different bacterial strains gives wide antibacterial activity. A combination therapy comprises administration of antibiotic and bacteriophage covalently attached to a carrier particle. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111867608-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017157186-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018195415-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3612200-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022238947-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3720459-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110799203-A |
priorityDate |
2014-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |